Table 5.
Gender-specific outcomes for subjective opioid effects
| Variables (VAS) | Median effect (IQR) | Incidence (%) | |||
|---|---|---|---|---|---|
| Women | Men | Women | Men | ||
| Sedation | 75 (60–85) | 70 (50–84) | 100 | 100 | |
| Dizziness | - average | 30 (0–60) | 5 (0–30) | 76 | 57 |
| - maximum | 50 (0–80) | 20 (0–50) | 76 | 59 | |
| Nausea | - average | 10 (0–40) | 0 (0–20) | 54 | 44 |
| - maximum | 25 (0–76) | 0 (0–50) | 54 | 45 | |
| Pruritus | - average | 20 (0–50) | 10 (0–32) | 73 | 68 |
| - maximum | 45 (0–70) | 20 (0–50) | 74 | 68 | |
| Liking | - average | 50 (0–75) | 50 (1–79) | 62 | 75 |
| - maximum | 70 (4–90) | 70 (50–90) | 75 | 89 | |
| Disliking | - maximum | 40 (0–85) | 30 (0–63) | 67 | 63 |
IQR = inter-quartile range, VAS = visual analog scale